Enovis Corporation ( ENOV) - Key Metrics
ENOV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $10.14 | -$9.17 | $1.56 | $0.57 |
| 2025Q3 | $9.67 | -$10.06 | $1.45 | $0.51 |
| 2025Q2 | $9.94 | -$0.65 | $0.84 | $0.06 |
| 2025Q1 | $9.84 | -$0.99 | -$0.03 | -$0.79 |
ENOV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -0.73 |
| 2025Q3 | ? | -0.80 |
| 2025Q2 | ? | -13.00 |
| 2025Q1 | ? | -8.25 |
ENOV Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -2.24% | ? |
| 2025Q4 | 2.13% | ? |
| 2025Q3 | 1.60% | ? |
| 2025Q2 | 0.18% | ? |
| 2025Q1 | -2.43% | ? |
ENOV
Price: $20.98
52 week price:
Payout Ratio Range:
Earnings Per Share: -19.89 USD
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 1.2 billion